Published in Proc Soc Exp Biol Med on February 01, 1982
Statistical problems in the reporting of clinical trials. A survey of three medical journals. N Engl J Med (1987) 8.64
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
Adverse nondrug reactions. N Engl J Med (1968) 5.26
Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev (1993) 4.69
High prevalence of benign prostatic hypertrophy in the community. Lancet (1991) 4.60
Validation of a semi-quantitative food frequency questionnaire: comparison with a 1-year diet record. J Am Diet Assoc (1987) 3.05
Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev (2000) 2.85
Dictyostelium myosin heavy chain phosphorylation sites regulate myosin filament assembly and localization in vivo. Cell (1993) 2.61
Positive direct Coombs tests due to cephalothin. N Engl J Med (1967) 2.26
A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma. Br J Dermatol (2004) 2.14
Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol Cell Biol (1998) 2.10
Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjug Chem (2001) 2.06
Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis. J Biol Chem (1999) 2.00
Metabolic changes associated with the cessation of cigarette smoking. Arch Environ Health (1970) 1.99
Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc Natl Acad Sci U S A (1996) 1.86
Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway. J Biol Chem (1999) 1.82
The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev (1999) 1.78
Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. N Engl J Med (1971) 1.76
Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer. Ann Intern Med (1977) 1.74
Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol (1983) 1.74
Electrophysiological laboratory, electrophysiologist-implanted, nonthoracotomy-implantable cardioverter/defibrillators. Circulation (1994) 1.73
Radiofrequency catheter ablation of atriofascicular and nodoventricular Mahaim tracts. Circulation (1994) 1.73
The biotransformation of drugs in renal failure. Am J Med (1977) 1.70
Radiofrequency catheter ablation of atrial arrhythmias. Results and mechanisms. Circulation (1994) 1.64
Quinidine elimination in patients with congestive heart failure or poor renal function. N Engl J Med (1974) 1.63
Fos family members induce cell cycle entry by activating cyclin D1. Mol Cell Biol (1998) 1.61
Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer. J Biol Chem (1998) 1.61
Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin. J Am Coll Cardiol (1994) 1.60
Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression. Eur J Pharmacol (1976) 1.57
"Cristal tachycardias": origin of right atrial tachycardias from the crista terminalis identified by intracardiac echocardiography. J Am Coll Cardiol (1998) 1.56
Activation and entrainment mapping defines the tricuspid annulus as the anterior barrier in typical atrial flutter. Circulation (1996) 1.56
Penile cancer: current therapy and future directions. Ann Oncol (2013) 1.54
Malignant fibrous histiocytoma: an institutional review. Cancer Invest (2001) 1.54
Angiotensin II activation of cyclin D1-dependent kinase activity. J Biol Chem (1996) 1.51
Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes. Proc Natl Acad Sci U S A (1999) 1.50
Clinical consequences of polymorphic acetylation of basic drugs. Clin Pharmacol Ther (1977) 1.50
Use of P wave configuration during atrial tachycardia to predict site of origin. J Am Coll Cardiol (1995) 1.48
Inhibition of 11beta-hydroxysteroid dehydrogenase by bioflavonoids and their interaction with furosemide and gossypol. J Lab Clin Med (1998) 1.47
Physiological sex steroid replacement in premature ovarian failure: randomized crossover trial of effect on uterine volume, endometrial thickness and blood flow, compared with a standard regimen. Hum Reprod (2012) 1.46
Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial. Breast Cancer Res Treat (2001) 1.46
Influence of disease on binding of drugs to plasma proteins. Ann N Y Acad Sci (1973) 1.43
Adverse drug reactions without drugs. Lancet (1967) 1.42
Factors predicting loss and gain of red cell volume in cardiac surgery patients. Transfus Med (2006) 1.42
Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart (2003) 1.39
Dietary intake of total and glycosylated vitamin B-6 and the vitamin B-6 nutritional status of unsupplemented lactating women and their infants. Am J Clin Nutr (1989) 1.38
Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist. J Pharmacol Exp Ther (1996) 1.38
Relationship between diazepam dose, plasma level, age, and central nervous system depression. Clin Pharmacol Ther (1978) 1.38
Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N Engl J Med (1978) 1.37
New algorithm for the localization of accessory atrioventricular connections using a baseline electrocardiogram. J Am Coll Cardiol (1994) 1.37
Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol (1996) 1.34
Polymorphic acetylation procainamide in man. Clin Pharmacol Ther (1975) 1.32
Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men. Br J Gen Pract (1993) 1.31
Optimizing metoclopramide control of cisplatin-induced emesis. Ann Intern Med (1984) 1.30
The binding of drugs to plasma proteins and the interpretation of measurements of plasma concentrations of drugs in patients with poor renal function. Am J Med (1977) 1.27
Relationship between prostate specific antigen, prostate volume and age in the benign prostate. Br J Urol (1993) 1.26
Atypical right atrial flutter patterns. Circulation (2001) 1.23
Electrophysiologic effects of adenosine in patients with supraventricular tachycardia. Circulation (1999) 1.23
Occupational physicians and their work: prospects for audit. Occup Med (Lond) (1993) 1.22
Epidemic of adenovirus-induced respiratory illness among US military recruits: epidemiologic and immunologic risk factors in healthy, young adults. J Med Virol (2001) 1.22
Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: an overview. Clin Pharmacol Ther (1986) 1.21
Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol. Proc Natl Acad Sci U S A (1995) 1.21
An audit of occupational medicine consultation records. Occup Med (Lond) (1994) 1.19
Electrophysiologic and antiarrhythmic effects of phentolamine in experimental coronary artery occlusion and reperfusion in the dog. J Cardiovasc Pharmacol (1980) 1.18
Use of electroanatomic mapping to delineate transseptal atrial conduction in humans. Circulation (1999) 1.16
Transforming potential of Dbl family proteins correlates with transcription from the cyclin D1 promoter but not with activation of Jun NH2-terminal kinase, p38/Mpk2, serum response factor, or c-Jun. J Biol Chem (1998) 1.14
Specific determination of quinidine and (3S)-3-hydroxyquinidine in human serum by high-pressure liquid chromatography. J Lab Clin Med (1977) 1.13
Steady-state serum levels of quinidine and active metabolites in cardiac patients with varying degrees of renal function. Clin Pharmacol Ther (1978) 1.13
Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: impact of treatment in paroxysmal and established atrial fibrillation. Am Heart J (1996) 1.12
Increased urinary enzyme excretion in workers exposed to nephrotoxic chemicals. Am J Med (1984) 1.12
The binding of drugs to plasma proteins from patients with poor renal function. Clin Pharmacokinet (1976) 1.11
Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancer. Ann Oncol (2011) 1.11
Radiofrequency catheter modification of sinus pacemaker function guided by intracardiac echocardiography. Circulation (1995) 1.10
Drug metabolism in uremia. Clin Nephrol (1975) 1.09
Some smokers lie. Clin Pharmacol Ther (1994) 1.07
Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate. J Nucl Med (1996) 1.07
Prevention of chronic radiation enteritis. J Am Coll Surg (1999) 1.06
Hydralazine elimination in man. Clin Pharmacol Ther (1974) 1.06
Biophysical characteristics of radiofrequency lesion formation in vivo: dynamics of catheter tip-tissue contact evaluated by intracardiac echocardiography. Am Heart J (1997) 1.06
Oral gossypol in the treatment of metastatic adrenal cancer. J Clin Endocrinol Metab (1993) 1.05
The protein binding of some drugs in plasma from patients with alcoholic liver disease. Eur J Clin Pharmacol (1975) 1.05
Intestinal cytosol binders of 1,25-dihydroxyvitamin D and 25-hydroxyvitamin D. Arch Biochem Biophys (1976) 1.05
Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging. Bioconjug Chem (1996) 1.05
Gossypol treatment of recurrent adult malignant gliomas. J Neurooncol (1999) 1.03
TELEMAM: a cluster randomised trial to assess the use of telemedicine in multi-disciplinary breast cancer decision making. Eur J Cancer (2007) 1.03
Gossypol inhibition of mitosis, cyclin D1 and Rb protein in human mammary cancer cells and cyclin-D1 transfected human fibrosarcoma cells. Br J Cancer (1997) 1.02
Investigation of factors which might indicate susceptibility to particulate air pollution. Occup Environ Med (2000) 1.02
How much time is needed for hand hygiene in intensive care? A prospective trained observer study of rates of contact between healthcare workers and intensive care patients. J Hosp Infect (2006) 1.02
Ventricular fibrillation-induced intracellular Ca2+ overload causes failed electrical defibrillation and post-shock reinitiation of fibrillation. J Mol Cell Cardiol (1998) 1.02
Aging and renal clearance of procainamide and acetylprocainamide. Clin Pharmacol Ther (1980) 1.01
Intestinal perforation from trauma to an inguinal hernia. Arch Fam Med (1995) 1.00
Alteration of drug-protein binding in renal disease. Clin Pharmacokinet (1984) 0.99
Sexual dysfunction, informed consent and multimodality therapy for rectal cancer. Am J Surg (2000) 0.99